US Physical Therapy Inc. diskutieren
US Physical Therapy Inc.
WKN: 923954 / Symbol: USPH / Name: US Physical / Aktie / Anbieter & Dienstleistungen / Small Cap /
96,00 €
-1,54 %
U.S. Physical Therapy, Inc. (NYSE: USPH) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $138.00 price target on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) was upgraded by analysts at CJS Securities from a "market perform" rating to an "outperform" rating.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target lowered by analysts at Barrington Research from $124.00 to $111.00. They now have an "outperform" rating on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target lowered by analysts at JPMorgan Chase & Co. from $108.00 to $99.00. They now have an "overweight" rating on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target raised by analysts at Barrington Research from $111.00 to $120.00. They now have an "outperform" rating on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target raised by analysts at Barrington Research from $120.00 to $122.00. They now have an "outperform" rating on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its price target raised by analysts at JPMorgan Chase & Co. from $99.00 to $117.00. They now have an "overweight" rating on the stock.
Ratings data for USPH provided by MarketBeat
U.S. Physical Therapy, Inc. (NYSE: USPH) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $122.00 price target on the stock.
Ratings data for USPH provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Protagonist Therapeutics Inc diskutieren